SCHEMBL2730283

SCHEMBL2730283

COC1(C)CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10382153 0.92
SCHEMBL3898307 0.89
SCHEMBL10421200 0.86
Water SCHEMBL25402677 0.83
SCHEMBL813728 0.81
SCHEMBL5167110 0.77
SCHEMBL7931708 0.74
SCHEMBL11597440 0.73
SCHEMBL27099538 0.73
SCHEMBL6778225 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0385724-B1 Improved method for preparing non-aqueous electrolytes DURACELL INC (US) 1993-12-15 EP claimed
EP-0385724-A2 Improved method for preparing non-aqueous electrolytes DURACELL INC. (US) 1990-09-05 EP claimed
US-4880714-A LITHIUM HEXAFLUOROPHOSPHATE, ELECTROLYTIC CELLS DURACELL INC. (US) 1989-11-14 US claimed
CN-120040390-A Method for preparing 2-alkoxy-2-methyltetrahydrofuran compound from 2-methylfuran 常州大学 2025-05-27 CN disclosed
WO-2021076629-A1 PROCESS OF PREPARING (1R, 4R, 5S)-4-(2-CHLOROETHYL)-1-((S)-((S)-CYCLOHEX-2-EN-1-YL)(HYDROXY)METHYL)-5-METHYL-6-OXA-2-AZABICYCLO[3.2.0]HEPTANE-3,7-DIONE(SALINOSPORAMIDE A; MARIZOMIB) CELGENE INTERNATIONAL II SARL (CH) 2021-04-22 WO disclosed
EP-2847208-B1 C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY VIIV HEALTHCARE UK (NO 5) LTD (GB) 2017-10-04 EP disclosed
EP-2632963-B1 HYDROGENATED STYRENE-BUTADIENE COPOLYMERS AND PROCESS FOR THEIR PREPARATION VERSALIS SPA (IT) 2015-08-05 EP disclosed
CN-103906738-A Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases GALDERMA RES & DEV 2014-07-02 CN disclosed
EP-2632963-A1 HYDROGENATED STYRENE-BUTADIENE COPOLYMERS AND PROCESS FOR THEIR PREPARATION versalis S.p.A. (IT) 2013-09-04 EP disclosed
WO-2012129967-A1 NEW AMINOPYRIDINE COMPOUNDS, THE PREPARATION METHOD, THE PHARMACEUTICAL COMPOSITIONS COMPRISING THESE COMPOUNDS AND THE USES THEREOF 中国科学院上海药物研究所 (CN) 2012-10-04 WO disclosed
WO-2012055802-A1 HYDROGENATED STYRENE-BUTADIENE COPOLYMERS AND PROCESS FOR THEIR PREPARATION POLIMERI EUROPA S.P.A. (IT) 2012-05-03 WO disclosed
US-20070219316-A1 PROCESS IN CONTINUOUS FOR THE PREPARATION OF RANDOM CONJUGATED DIENE/VINYL ARENE COPOLYMERS POLIMERI EUROPA S.P.A (IT) 2007-09-20 US disclosed
EP-1829906-A1 Continuous process for the preparation of random conjugated diene/vinyl arene copolymers Polimeri Europa S.p.A. (IT) 2007-09-05 EP disclosed
WO-2007022638-A1 BENZODIAZEPINE AND BENZOPIPERAZINE ANALOG INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2007-03-01 WO disclosed
CN-1916139-A Method for improving power transmission performance and composition thereof AFTON CHEMICAL CORP (US) 2007-02-21 CN disclosed
EP-0385724-B1 Improved method for preparing non-aqueous electrolytes DURACELL INC (US) 1993-12-15 EP disclosed
EP-0385724-A2 Improved method for preparing non-aqueous electrolytes DURACELL INC. (US) 1990-09-05 EP disclosed
US-4880714-A LITHIUM HEXAFLUOROPHOSPHATE, ELECTROLYTIC CELLS DURACELL INC. (US) 1989-11-14 US disclosed
EP-0020941-B1 SUBSTITUTED 3-(1-PYRROLIDINYL)-5-SULFAMOYL-BENZOIC ACID DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND A PROCESS FOR THE PREPARATION THEREOF HOECHST AKTIENGESELLSCHAFT (DE) 1983-06-29 EP disclosed
US-4261818-A Method for making separations from aqueous solutions SWEENEY MAXWELL P 1981-04-14 US disclosed